Lorentz Samuel G, Hurley Eoghan T, Meyer Alex M, Glover Mark A, Dickens Jonathan F, Provencher Matthew T
Department of Orthopaedic Surgery, Duke University, Durham, North Carolina, U.S.A..
Department of Orthopaedic Surgery, Duke University, Durham, North Carolina, U.S.A.
Arthroscopy. 2025 May 13. doi: 10.1016/j.arthro.2025.05.007.
To systematically review the literature to evaluate the clinical and biomechanical results of distal tibial allograft (DTA) for shoulder instability.
A literature search of the MEDLINE, Embase, and Cochrane Library databases was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Clinical and biomechanical studies reporting the results of DTA for shoulder instability were included. Qualitative and quantitative data were evaluated.
A total of 9 clinical and 7 biomechanical studies were included. A total of 341 patients with an average age of 25.5 to 31 years were included in the clinical analysis. Cohorts ranged from 61.9% to 100% male, and average glenoid bone loss ranged from 20% to 33%. The recurrent dislocation rate after DTA procedures ranged from 0% to 2.0%. Mean preoperative Single Assessment Numeric Evaluation scores ranged from 32.2 to 50, whereas postoperative scores ranged from 85 to 91. Mean preoperative American Shoulder and Elbow Surgeons scores ranged from 40 to 63, whereas postoperative scores ranged from 90.5 to 92. Postoperative forward flexion ranged from 156.8° to 177°. The union rate on postoperative computed tomography scans was 90.3% to 100%, with rates of significant resorption (>50%) ranging from 8.1% to 16%. Biomechanical studies showed that DTA resulted in improved contact pressures, contact areas, and stability when compared with cadaveric models with simulated glenoid bone loss.
The literature on DTA for the management of anterior shoulder instability with glenoid bone loss shows overall excellent results with low rates of recurrent instability and high patient-reported outcome (PRO) scores. Biomechanical studies show that glenoid reconstruction with DTA provides near anatomic reconstruction, leading to increased stability, improved contact area, and decreased loading pressures.
The findings of the biomechanical review show that DTA provides highly congruent grafts for glenoid reconstruction. This is important for short-term outcomes including redislocations and PROs, as well as longer-term outcomes including osteoarthritis. Our review of Level III and IV clinical studies shows the clinical implications, with low rates of recurrent instability and high PRO scores.
系统回顾文献,评估胫骨远端异体骨(DTA)治疗肩关节不稳的临床和生物力学结果。
根据系统评价和Meta分析的首选报告项目指南,对MEDLINE、Embase和Cochrane图书馆数据库进行文献检索。纳入报告DTA治疗肩关节不稳结果的临床和生物力学研究。对定性和定量数据进行评估。
共纳入9项临床研究和7项生物力学研究。临床分析共纳入341例患者,平均年龄25.5至31岁。队列中男性比例为61.9%至100%,平均肩胛盂骨丢失率为20%至33%。DTA手术后复发性脱位率为0%至2.0%。术前单评估数字评分平均范围为32.2至50,而术后评分范围为85至91。术前美国肩肘外科医师评分平均范围为40至63,而术后评分范围为90.5至92。术后前屈范围为156.8°至177°。术后计算机断层扫描的愈合率为90.3%至100%,显著吸收(>50%)率为8.1%至16%。生物力学研究表明,与模拟肩胛盂骨丢失的尸体模型相比,DTA可改善接触压力、接触面积和稳定性。
关于DTA治疗伴有肩胛盂骨丢失的前肩关节不稳的文献显示,总体结果优异,复发性不稳率低,患者报告结局(PRO)评分高。生物力学研究表明,用DTA进行肩胛盂重建可提供接近解剖学的重建,从而提高稳定性、改善接触面积并降低负荷压力。
生物力学综述的结果表明,DTA为肩胛盂重建提供高度匹配的移植物。这对于包括再脱位和PROs在内的短期结果以及包括骨关节炎在内的长期结果都很重要。我们对III级和IV级临床研究的综述显示了临床意义,复发性不稳率低,PRO评分高。